Unrecognized Tax Benefits of CytomX Therapeutics, Inc. from 31 Dec 2012 to 31 Dec 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of unrecognized tax benefits.
Summary
CytomX Therapeutics, Inc. quarterly Unrecognized Tax Benefits in USD history and change rate from 31 Dec 2012 to 31 Dec 2024.
  • CytomX Therapeutics, Inc. Unrecognized Tax Benefits for the quarter ending 31 Dec 2024 was $19,994,000, a 3.2% increase year-over-year.
Source SEC data
View on sec.gov
Unrecognized Tax Benefits, Quarterly (USD)
Unrecognized Tax Benefits, YoY Quarterly Change (%)

CytomX Therapeutics, Inc. Quarterly Unrecognized Tax Benefits (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2024 $19,994,000 +$617,000 +3.2% 31 Dec 2024 10-K 06 Mar 2025 2024 FY
Q4 2023 $19,377,000 +$10,108,000 +109% 31 Dec 2023 10-K 06 Mar 2025 2024 FY
Q4 2022 $9,269,000 +$1,489,000 +19% 31 Dec 2022 10-K 06 Mar 2025 2024 FY
Q4 2021 $7,780,000 +$1,326,000 +21% 31 Dec 2021 10-K 11 Mar 2024 2023 FY
Q4 2020 $6,454,000 +$1,205,000 +23% 31 Dec 2020 10-K 27 Mar 2023 2022 FY
Q4 2019 $5,249,000 +$1,493,000 +40% 31 Dec 2019 10-K/A 27 Mar 2023 2021 FY
Q4 2018 $3,756,000 -$564,000 -13% 31 Dec 2018 10-K/A 27 Mar 2023 2021 FY
Q4 2017 $4,320,000 +$3,138,000 +265% 31 Dec 2017 10-K 24 Feb 2021 2020 FY
Q4 2016 $1,182,000 +$516,000 +77% 31 Dec 2016 10-K 27 Feb 2020 2019 FY
Q4 2015 $666,000 -$2,353,000 -78% 31 Dec 2015 10-K 27 Feb 2019 2018 FY
Q4 2014 $3,019,000 +$2,487,000 +467% 31 Dec 2014 10-K 07 Mar 2018 2017 FY
Q4 2013 $532,000 +$332,000 +166% 31 Dec 2013 10-K 02 Mar 2017 2016 FY
Q4 2012 $200,000 31 Dec 2012 10-K 07 Mar 2016 2015 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.